Engineers Gate Manager’s Satsuma Pharmaceuticals, Inc. Common Stock STSA Stock Holding History

Engineers Gate Manager’s Portfolio STSA Stock Details STSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-11,273	Closed	-$51K	–	2458
2021 Q4	$51K	Sell	11,273 -7,254	-39%	-$36.8K	﹤0.01%	1868
2021 Q3	$86K	Buy	18,527 +919	+5%	+$4.87K	﹤0.01%	1548
2021 Q2	$124K	Buy	17,608 +318	+2%	+$1.71K	0.01%	1473
2021 Q1	$102K	Buy	17,290 +3,612	+26%	+$21.9K	0.01%	1704
2020 Q4	$63K	Sell	13,678 -10,522	-43%	-$45.4K	﹤0.01%	1624
2020 Q3	$94K	Buy	+24,200	New	+$486K	﹤0.01%	1566

Other funds holding STSA

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GTC

Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return

Engineers Gate Manager's STSA Position: Q1 2022 in Review

Engineers Gate Manager sold out of Satsuma Pharmaceuticals, Inc. Common Stock (STSA) in Q1 2022, closing a stake of 11,273 shares — an estimated $51K sold.

Engineers Gate Manager first reported a position in STSA in Q3 2020 and held it in 6 quarters. The position peaked at $124K in Q2 2021. 36 funds tracked by Wall St. Rank hold STSA as of Q1 2022.

Engineers Gate Manager reported no remaining Satsuma Pharmaceuticals, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
Engineers Gate Manager sold 11,273 Satsuma Pharmaceuticals, Inc. Common Stock shares in Q1 2022, an estimated $51K.
Engineers Gate Manager first reported a position in Satsuma Pharmaceuticals, Inc. Common Stock in Q3 2020 and held it in 6 quarters.
Engineers Gate Manager's Satsuma Pharmaceuticals, Inc. Common Stock position peaked at $124K in Q2 2021.
36 funds tracked by Wall St. Rank held Satsuma Pharmaceuticals, Inc. Common Stock as of Q1 2022.

Based on Engineers Gate Manager's 13F filing for Q1 2022, filed 16 May 2022.